TY - JOUR
T1 - Long-term survival case after liver resection and postoperative hepatic arterial infusion for multiple liver metastases from rectal cancer
AU - Kitamura, Yo
AU - Katayose, Yu
AU - Miura, Koh
AU - Yamamoto, Kuniharu
AU - Yoshida, Hiroshi
AU - Ottomo, Shigeru
AU - Motoi, Fuyuhiko
AU - Rikiyama, Toshiki
AU - Egawa, Shinichi
AU - Sasaki, Iwao
AU - Unno, Michiaki
PY - 2010/11
Y1 - 2010/11
N2 - A 45-year-old man underwent a low anterior resection for rectal cancer [T3, N1, MO, Stage Ha: UICCJ. He received a postoperative systemic chemotherapy with 5-FU and LV. Five months after the operation, multiple liver metastases were detected in the right hepatic lobe (S5, 6, 8). Right hepatectomy was performed. Seventeen courses of postoperative hepatic arterial infusion (HAI) chemotherapy (weekly high-dose 5-FU regimen) were performed without severe adverse events. He was still alive with no sign of recurrence for 69 months after hepatectomy. After liver resection for metastases of colorectal cancer, although a systemic chemotherapy has been mainly performed, HAI chemotherapy is one of the important options for prevention of local recurrence.
AB - A 45-year-old man underwent a low anterior resection for rectal cancer [T3, N1, MO, Stage Ha: UICCJ. He received a postoperative systemic chemotherapy with 5-FU and LV. Five months after the operation, multiple liver metastases were detected in the right hepatic lobe (S5, 6, 8). Right hepatectomy was performed. Seventeen courses of postoperative hepatic arterial infusion (HAI) chemotherapy (weekly high-dose 5-FU regimen) were performed without severe adverse events. He was still alive with no sign of recurrence for 69 months after hepatectomy. After liver resection for metastases of colorectal cancer, although a systemic chemotherapy has been mainly performed, HAI chemotherapy is one of the important options for prevention of local recurrence.
KW - Hepatic arterial infusion
KW - Long-term survival
KW - Multiple liver metastases
KW - Rectal cancer
UR - http://www.scopus.com/inward/record.url?scp=84866605549&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84866605549&partnerID=8YFLogxK
M3 - Article
C2 - 21224665
AN - SCOPUS:84866605549
SN - 0385-0684
VL - 37
SP - 2641
EP - 2643
JO - Japanese Journal of Cancer and Chemotherapy
JF - Japanese Journal of Cancer and Chemotherapy
IS - 12
ER -
